Equities
Basic MaterialsChemicals
  • Price (EUR)119.75
  • Today's Change1.75 / 1.48%
  • Shares traded48.65k
  • 1 Year change-27.53%
  • Beta1.2999
Data delayed at least 15 minutes, as of Sep 30 2022 13:07 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

IMCD NV is a company based in the Netherlands that specializes in sales, marketing and distribution of specialty chemicals and foods ingredients. Its product portfolio includes chemicals from various areas, including pharmaceutics, personal care, coatings, food and nutrition, lubricants, synthesis, plastics, detergents, agrochemicals, textile, waste and water treatment, cutting and sand blasting, flavors and fragrances, oil and gas and polishing, among others. The Company operates an international supply chain with local warehouses and provides valued-added services, including repacking, dilution and blending. The Company operates worldwide.

  • Revenue in EUR (TTM)4.08bn
  • Net income in EUR278.97m
  • Incorporated1995
  • Employees4.01k
  • Location
    IMCD NVWilhelminaplein 32ROTTERDAM 3072 DENetherlandsNLD
  • Phone+31 102908684
  • Fax+31 102908680
  • Websitehttp://www.imcdgroup.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
IMCD:AEX since
announced
Transaction
value
Promaplast Resinas SA de CVAnnounced23 Aug 202223 Aug 2022Announced-19.03%--
Welex SA Holdings (China) LtdAnnounced21 Jun 202221 Jun 2022Announced-3.54%--
Quelaris Internacional SAAnnounced17 Feb 202217 Feb 2022Announced-16.05%--
Polychem Handeslgesellschaft MbhAnnounced23 Dec 202123 Dec 2021Announced-37.43%--
PT Megasetia Agung KimiaAnnounced17 Nov 202117 Nov 2021Announced-40.05%--
Data delayed at least 15 minutes, as of Sep 30 2022 13:07 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
VERBIO Vereinigte BioEnergie AG1.55bn231.45m3.44bn958.0014.834.7513.122.233.663.6624.5111.421.949.3917.101,886,224.0029.0712.5835.9615.2628.7216.5414.986.751.989.560.06222.8317.619.4147.0513.8438.615.92
Johnson Matthey PLC18.15bn131.37m3.85bn14.42k30.341.4111.120.21240.6115-0.528883.6513.172.228.908.211,111,227.001.614.013.036.666.587.360.72391.900.8368.800.338554.783.825.90-40.21-21.3711.790.5277
Azelis Group3.54bn160.41m5.10bn3.18k31.782.0621.441.440.6860.68615.1210.560.8425.717.281,113,278.003.91--4.73--23.51--4.65--1.174.370.3537--27.19---4.52------
Clariant AG5.12bn361.28m5.31bn11.25k14.601.857.851.041.051.7314.858.280.69434.216.50366,457.305.302.218.053.1929.1630.647.633.660.8446--0.3475197.0013.26-5.65151.891.081.39-2.33
Arkema SA10.97bn1.07bn5.51bn20.20k5.210.75613.240.502014.2314.23145.6698.030.84915.986.52568,194.808.416.6310.458.0724.5121.789.917.981.3035.560.319727.6720.744.79325.3324.819.627.91
Chr Hansen Holding A/S1.18bn229.91m6.80bn3.95k29.523.9220.305.7512.9913.1166.8197.910.37743.406.812,229,261.007.3310.128.4312.7355.9457.4019.4421.610.838411.860.358361.3511.072.57-14.211.5714.8320.14
Imcd NV4.08bn278.97m6.87bn4.01k24.624.2718.401.684.904.9071.6328.241.216.005.541,090,717.008.305.6411.717.8221.7820.286.844.651.0419.700.450744.4723.8014.9172.5523.2223.7224.12
Umicore SA25.22bn527.96m7.43bn11.35k13.802.128.380.29482.192.19104.4114.202.577.6311.341,848,767.005.424.899.728.125.856.512.111.840.859910.940.412735.6116.1518.16374.1927.877.673.83
Oci NV9.29bn1.26bn7.59bn3.72k6.032.642.300.81755.975.9744.0113.670.917315.3111.652,500,045.0023.631.8337.312.5834.9420.6525.764.151.3416.480.4092--81.8827.08421.0527.71-19.49--
Evonik Industries AG17.23bn944.00m8.16bn33.24k8.660.73274.030.47362.022.0436.9523.900.77474.738.05522,088.204.333.355.374.0125.4728.765.595.130.845366.750.317379.0822.593.2752.970.00-1.540.3454
Brenntag SE17.37bn753.50m9.55bn17.22k12.672.128.540.54944.884.88112.4529.141.718.326.761,008,018.007.605.5111.637.6622.7822.244.443.520.95913.800.400941.7221.946.50-3.904.477.506.67
Yara International ASA22.54bn1.55bn9.70bn17.80k6.261.233.890.430563.8763.87929.36326.361.244.2310.3813,299,220.008.172.8111.523.5727.4126.576.603.500.68459.310.3434150.2943.367.93-35.02-9.93-12.0023.39
Data as of Sep 30 2022. Currency figures normalised to IMCD NV's reporting currency: Euro EUR

Institutional shareholders

43.24%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 24 Aug 20225.70m10.00%
Capital Research & Management Co. (World Investors)as of 30 Jun 20224.29m7.54%
BlackRock Investment Management (UK) Ltd.as of 22 Sep 20222.69m4.72%
Baillie Gifford & Co.as of 22 Sep 20222.29m4.02%
Capital Research & Management Co. (Global Investors)as of 30 Jun 20222.15m3.78%
Citigroup Global Markets Ltd. (Investment Management)as of 13 Apr 20211.87m3.29%
Norges Bank Investment Managementas of 31 Dec 20201.52m2.67%
The Vanguard Group, Inc.as of 09 Sep 20221.50m2.63%
Marshall Wace LLPas of 25 May 20211.33m2.33%
Jupiter Asset Management Ltd.as of 31 May 20221.30m2.28%
More ▼
Data from 31 Dec 2021 - 01 Sep 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.